Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has released an update on its both its financial and corporate status. According to the announcement, the company released its first end-of-year earnings report in May, which showed $1.5 million annual revenue and a growth in net assets from $2.1 million in 2020 to $10 million by 2021 year end, a 500% year-over-year increase. In addition, the company’s Ketamine Wellness Centers (“KWC”) are reporting impressive growth, offering an estimated 100,000 treatments so far at its 13 operational, state-of-the-art clinics; the company most recently started offering SPRAVATO(R), the FDA-approved esketamine nasal spray, at its Houston, Las Vegas, Seattle, Minneapolis, Salt Lake City and Dallas locations, with more locations planning to offer the treatment soon. In addition, centers in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson have introduced NAD+ infusion therapy, with plans to expand that offering nationwide. Delic’s centers also partnered with the Veterans Administration in Arizona and launched the Ketamine Wellness Integrative Therapist Directory, which is designed to connect KWC patients with qualified mental health practitioners. “I’m very excited to say Delic Corp is thriving and continuing to grow as evidenced by the revenue we generated in our first full year of operation,” said Delic Holdings cofounder and CEO Matt Stang in the press release. “We have a strong team across all the businesses and I’m proud of the work we have done so far to make these life-changing therapies more affordable and accessible, while also working to change the perception of psychedelics and mental health. However, there are still too many people suffering with mental health conditions who are not aware of the help available to them right now. We will continue to find solutions to these challenges and make sure the treatments are more affordable and everyone who needs these therapies has access to them.”
To view the full press release, visit https://ibn.fm/09Pxy
About Delic Holdings
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including Ketamine Wellness Centers, the largest chain of psychedelic wellness clinics in the country; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premier psychedelic wellness event; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products and effective treatment options to the masses. For more information about the company, visit www.DelicCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
